(Q34537487)

2 August 2017

title

Virologic and Immunologic Response to Highly Active Antiretroviral Therapy (English)

1 reference

2 August 2017

0 references

anti-retroviral agent

0 references

author name string

Lisa P. Jacobson

series ordinal

1

1 reference

2 August 2017

John P. Phair

series ordinal

2

1 reference

2 August 2017

Traci E. Yamashita

series ordinal

3

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Current infectious disease reports

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

88-96

1 reference

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-002-0072-5

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-002-0072-5

Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-002-0072-5

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-002-0072-5

Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-002-0072-5

Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-002-0072-5

Response to highly active antiretroviral therapy according to duration of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-002-0072-5

Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-002-0072-5

Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-002-0072-5

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

21 January 2018

1 reference

12 December 2020

Changes in thymic function with age and during the treatment of HIV infection

1 reference

12 December 2020

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy

1 reference

12 December 2020

CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load

1 reference

12 December 2020

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study

1 reference

12 December 2020

Decline in deaths from AIDS due to new antiretrovirals

1 reference

12 December 2020

HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load

1 reference

12 December 2020

Effects of virologic rebound on CD4 cell counts

1 reference

12 December 2020

Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy

1 reference

12 December 2020

Clinical, Biologic, and Behavioral Predictors of Early Immunologic and Virologic Response in HIV-Infected Patients Initiating Protease Inhibitors

1 reference

12 December 2020

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

12 December 2020

Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy

1 reference

12 December 2020

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine

1 reference

12 December 2020

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

12 December 2020

The Multicenter AIDS Cohort Study: retention after 9 1/2 years

1 reference

12 December 2020

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients

1 reference

12 December 2020

Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.

1 reference

12 December 2020

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

12 December 2020

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Association of the CCR5delta32 mutation with improved response to antiretroviral therapy

1 reference

12 December 2020

Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program

1 reference

12 December 2020

Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

12 December 2020

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.

1 reference

12 December 2020

Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy

1 reference

12 December 2020

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.

1 reference

12 December 2020

Therapy naivete in the era of potent antiretroviral therapy

1 reference

12 December 2020

Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

1 reference

12 December 2020

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

12 December 2020

Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome.

1 reference

12 December 2020

Virological and immunological response to HAART therapy in a community-based cohort of HIV-1-positive individuals

1 reference

12 December 2020

Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients

1 reference

12 December 2020

Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease.

1 reference

12 December 2020

Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function

1 reference

12 December 2020

The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's interagency HIV study

1 reference

12 December 2020

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

12 December 2020

Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression

1 reference

12 December 2020

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

12 December 2020

Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus

1 reference

12 December 2020

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.

1 reference

12 December 2020

Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen

1 reference

12 December 2020

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

1 reference

12 December 2020

Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection

1 reference

12 December 2020

Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease.

1 reference

12 December 2020

HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism.

1 reference

12 December 2020

Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study

1 reference

12 December 2020

Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group.

1 reference

12 December 2020

Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study.

1 reference

12 December 2020

Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study

1 reference

12 December 2020

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

1 reference

12 December 2020

CCR5Δ32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response

1 reference

12 December 2020

Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection.

1 reference

12 December 2020

10.1007/S11908-002-0072-5

Identifiers

DOI

1 reference

2 August 2017

1 reference